olmesartan has been researched along with Aldosteronism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ceolotto, G; Cesari, M; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM | 1 |
1 other study(ies) available for olmesartan and Aldosteronism
Article | Year |
---|---|
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles | 2020 |